AUTL
Autolus Therapeutics
$1.46
+$0.01 (+0.69%)Jul 27, 2026
Key metrics
The numbers that frame AUTL today
- Market cap
- $388.59M
- P/E (TTM)
- -1.3
- EV / FCF
- -2.2
- Gross margin
- -11.2%
- EV / Sales
- 6.8
- ROIC
- -32.9%
- Div yield
- 0%
- Debt / equity
- 3.4
- 52wk Low
- $1.18
- 52wk High
- $2.66
Growth
Revenue and earnings trend for AUTL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AUTL
Is Autolus Therapeutics a good buy?
No. Autolus Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Autolus Therapeutics is selling at a very high price.
What is the market capitalization of AUTL?
Autolus Therapeutics's market capitalization is $388.59M.
What is the P/E ratio for AUTL stock?
Autolus Therapeutics's current P/E ratio is -1.3.
What is the 52-week high for AUTL stock?
The 52-week high for Autolus Therapeutics is $2.66. The current close of $1.46 is 45.1% below that high.
What is the 52-week low for AUTL stock?
The 52-week low for Autolus Therapeutics is $1.18. The current close of $1.46 is 24.3% above that low.
Does AUTL stock pay dividends?
Autolus Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AUTL?
Autolus Therapeutics's Debt / Equity ratio is 3.39.